EX-PRESS shunt implantation in Chinese glaucoma patients: 1-year results

Authors

  • Jennifer WH Shum Department of Ophthalmology, The University of Hong Kong, Hong Kong
  • Bonnie NK Choy Department of Ophthalmology, The University of Hong Kong, Hong Kong
  • Jonathan CH Chan Department of Ophthalmology, The University of Hong Kong, Hong Kong
  • Wing Lau Ho Department of Ophthalmology, Queen Mary Hospital, Hong Kong
  • Stephanie Cheri Woo The University of Hong Kong
  • Jimmy SM Lai Department of Ophthalmology, The University of Hong Kong, Hong Kong

Abstract

Aim: To report the safety and efficacy of EX-PRESS glaucoma filtration device implantation in Chinese glaucoma patients.

Methods: Records of 38 eyes from 38 Chinese glaucoma patients who underwent EX-PRESS shunt implantation between August 2012 and June 2014 with at least 1 year of follow-up were retrospectively reviewed. Main outcome measures included intraocular pressure (IOP), visual acuity, success rate, number of topical antiglaucoma medications applied, and postoperative complications.

Results: The mean IOP reduced significantly from 25.8±12.4 mmHg before surgery to 15.1±6.3 mmHg at 1 year after surgery (p<0.005). Repeated measures ANOVA showed that IOP at all time points after surgery was significantly lower than IOP before surgery. 73.7% of patients achieved complete or qualified success.

Conclusions: EX-PRESS shunt implantation is safe and effective in Chinese patients.

Downloads

Published

2019-08-12

How to Cite

1.
Shum JW, Choy BN, Chan JC, Ho WL, Woo SC, Lai JS. EX-PRESS shunt implantation in Chinese glaucoma patients: 1-year results. Hong Kong J Ophthalmol [Internet]. 2019Aug.12 [cited 2023Mar.28];23(1):7-11. Available from: https://hkjo.hk/index.php/hkjo/article/view/260

Issue

Vol. 23 No. 1 (2019)

Section

Original Articles

License

Copyright (c) 2019 Hong Kong Journal of Ophthalmology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The Journal has a fully Open Access policy and publishes all articles under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. For any use other than that permitted by this license, written permission must be obtained from the Journal.